Video: Q&A With Fred Hassan, Former CEO Of Schering-Plough

With the recent announcement of the Merck & Co acquisition of Schering & Plough, Fred Hassan the former Chief Executive Officer has been speaking to Meettheboss.TV on the future of the pharmaceutical Industry, mergers, acquisitions and the resistance felt.

Last year Fred over saw the $41.1 billion sale and predicts that more mergers and acquisitions should be expected throughout 2010. Company investments are a necessity for the funding of key research and development projects. "Innovation costs, but is the price too high for those involved?"

Fred speaks out during this candid interview how he dealt with a plethora of financial pressures and resistance. Shearing Plough were under FDA investigation as well as the SEC for accounting irregularities and although Fred saw this as a challenge it was not an impossible one.